Results 31 to 40 of about 70,747 (277)
Trials, 2009 Background Statins have anti-inflammatory and immunomodulatory properties in addition to their lipid-lowering effects. Currently, the effects of statins on multiple sclerosis are still controversial.
Mattle Heinrich P, Kamm Christian P
doaj +1 more source
Interferon Beta-1b Level in Parkinson’s Disease: Before and After SARS-CoV-2 Vaccination [PDF]
International Clinical Neuroscience Journal, 2022 Background: Parkinson’s disease (PD) is a neurodegenerative disease. Immune response varies after vaccination in different patients. We aimed to evaluate interferon beta-1b (IFNβ-1b) level in patients with PD in response to inactivated SARS-CoV-2 ...
Yaprak Dönmez Çakıl +3 more
doaj +1 more source
The Therapeutic Effect of Avonex, Rebif and Betaferon on EDSS and Relapse in Multiple Sclerosis: A Comparative Study [PDF]
Acta Medica Iranica, 2010 We aimed to compare the therapeutic effect of Avonex (Av), Betaferon (Be) & Rebif (Re) on the Expanded Disability Status Scale (EDSS) in Multiple Sclerosis (MS). Ninety patients referring to Farshchian Hospital were entered in this study.
Mehrdokht Mazdeh +2 more
doaj +1 more source
Acta Biomedica Scientifica, 2020 Background. The ability to control regeneration processes is a key link in the development of methods for treating patients with post-traumatic disorders of reparative osteogenesis. Aim of the study.
V. F. Lebedev +3 more
doaj +1 more source
Next-generation version of recombinant human interferon-beta: A molecular dynamic simulation study
Informatics in Medicine Unlocked, 2022 The ability of recombinant human interferon beta-1b (IFNβ-1b) to elicit the production of anti-IFNβ-1b antibodies becomes a significant issue for interferon therapy in patients.
Mohadeseh Haji Abdolvahab +3 more
doaj +1 more source
The Egyptian Journal of Internal Medicine, 2020 Background Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system with varied clinical features. Disease-modifying drugs (DMDs) of MS associated with different types of thyroiditis.
Nearmeen M. Rashad +3 more
doaj +1 more source
Безопасность и риск фармакотерапии, 2019 Multiple sclerosis is one of the most common neurological diseases of working age population. The last 20 years widely use drugs that change the course of multiple sclerosis.
K. E. Zatolochina +3 more
doaj +1 more source
Безопасность и риск фармакотерапии, 2019 Presently, an active search for modern drugs for the treatment of multiple sclerosis is ongoing. Since the treatment with original drugs is expensive, therefore, the development of local biosimilars is underway, which at a lower cost should be ...
D. O. Gudz +4 more
doaj +1 more source
Indian Journal of Community Medicine, 2023 The COVID-19 pandemic has caused havoc in the health sector. Inflammatory cytokines play an important role in the disease condition. Existing evidence has provided certain insights into the repurposing of the drugs.
Greeshma Sai Sree Nayudu +4 more
doaj +1 more source
مجله دانشکده پزشکی اصفهان, 2018 Background: Treatment has a major effect on attacks in patients with multiple sclerosis (MS). This study aimed to determine the effect of the type of used drug on occurrence and number of attacks in patients with multiple sclerosis.
Marjan Jamalian +4 more
doaj +1 more source